{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T09:24:50Z","timestamp":1789809890781,"version":"4.0.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2011,7,8]],"date-time":"2011-07-08T00:00:00Z","timestamp":1310083200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1007\/s00432-011-1002-4","type":"journal-article","created":{"date-parts":[[2011,7,7]],"date-time":"2011-07-07T06:41:59Z","timestamp":1310020919000},"page":"1329-1336","source":"Crossref","is-referenced-by-count":14,"title":["Molecular cytogenetic characterization of Philadelphia-negative rearrangements in chronic myeloid leukemia patients"],"prefix":"10.1007","volume":"137","author":[{"given":"Ayda","family":"Bennour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatem","family":"Bell\u00e2aj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosra","family":"Ben Youssef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moez","family":"Elloumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abderrahim","family":"Khelif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Saad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halima","family":"Sennana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,7,8]]},"reference":[{"key":"1002_CR1","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.cancergencyto.2007.11.007","volume":"181","author":"A Bennour","year":"2008","unstructured":"Bennour A, Sennana H, Laatiri MA, Khelif A, Saad A (2008) A masked BCR\/ABL rearrangement in a case of chronic myeloid leukemia with translocation t(3;9)(p14;q34). Cancer Genet Cytogenet 181:72\u201374","journal-title":"Cancer Genet Cytogenet"},{"key":"1002_CR2","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.cancergencyto.2009.05.010","volume":"194","author":"A Bennour","year":"2009","unstructured":"Bennour A, Sennana H, Laatiri MA, Elloumi M, Khelif A, Saad A (2009) Molecular cytogenetic characterization of variant Philadelphia translocations in chronic myeloid leukemia: genesis and deletion of derivative chromosome 9. Cancer Genet Cytogenet 194:30\u201337","journal-title":"Cancer Genet Cytogenet"},{"key":"1002_CR3","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1136\/jcp.2010.078311","volume":"63","author":"A Bennour","year":"2010","unstructured":"Bennour A, Beaufils N, Sennana H et al (2010) E355G mutation appearing in a patient with e19a2 chronic myeloid leukaemia resistant to imatinib. J Clin Pathol 63:737\u2013740","journal-title":"J Clin Pathol"},{"key":"1002_CR4","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cancergencyto.2007.06.013","volume":"178","author":"MGV Campos","year":"2007","unstructured":"Campos MGV, Montesano FT, Maria Madalena Rodrigues MM, Chauffaille MLLF (2007) Clinical implications of der(9q) deletions detected through dual-fusion fluorescence in situ hybridization in patients with chronic myeloid leukemia. Cancer Genet Cytogenet 178:49\u201356","journal-title":"Cancer Genet Cytogenet"},{"key":"1002_CR5","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.cancergencyto.2008.01.007","volume":"182","author":"VA Melo De","year":"2008","unstructured":"De Melo VA, Milojkovic D, Marin D, Apperley JF, Nacheva EP, Reid AG (2008) Deletions adjacent to BCR and ABL1 breakpoints occur in a substantial minority of chronic myeloid leukemia patients with masked Philadelphia rearrangements. Cancer Genet Cytogenet 182:111\u2013115","journal-title":"Cancer Genet Cytogenet"},{"key":"1002_CR6","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1182\/blood.V96.10.3343","volume":"96","author":"MWN Deininger","year":"2000","unstructured":"Deininger MWN, Goldman JM, Melo JV (2000) The molecular biology of chronic myeloid leukemia. Blood 96:3343\u20133356","journal-title":"Blood"},{"issue":"7","key":"1002_CR7","first-page":"952","volume":"91","author":"N Fourouclas","year":"2006","unstructured":"Fourouclas N, Campbell PJ, Bench AJ, Swanton S, Baxter EJ, Huntly BJ et al (2006) Size matters: the prognostic implications of large and small deletions of the derivative 9 chromosome in chronic myeloid leukemia. Haematologica 91(7):952\u2013955","journal-title":"Haematologica"},{"key":"1002_CR8","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.cancergencyto.2005.05.010","volume":"163","author":"G Fugazza","year":"2005","unstructured":"Fugazza G, Garuti A, Marchelli S, Miglino M, Bruzzone R, Gatti AM, Castello S, Sessarego M (2005) Masked Philadelphia chromosome due to atypical BCR\/ABL localization on the 9q34 band and duplication of the der (9) in a case of chronic myelogenous leukemia. Cancer Genet Cytogenet 163:173\u2013175","journal-title":"Cancer Genet Cytogenet"},{"key":"1002_CR9","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.cancergencyto.2006.10.006","volume":"173","author":"M Gorusu","year":"2007","unstructured":"Gorusu M, Benn P, Li Z, Fang M (2007) On the genesis and prognosis of variant translocations in chronic myeloid leukemia. Cancer Genet Cytogenet 173:97\u2013106","journal-title":"Cancer Genet Cytogenet"},{"key":"1002_CR10","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.cancergencyto.2004.02.026","volume":"155","author":"S Haigh","year":"2004","unstructured":"Haigh S, Cuthbert G (2004) Fluorescence in situ hybridization characterization of different cryptic BCR\/ABL rearrangements in chronic myeloid leukemia. [Erratum in: Cancer Genet Cytogenet 2005;156:188\u20139]. Cancer Genet Cytogenet 155:132\u2013137","journal-title":"Cancer Genet Cytogenet"},{"key":"1002_CR11","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1182\/blood-2002-09-2763","volume":"102","author":"BJ Huntly","year":"2003","unstructured":"Huntly BJ, Guilhot F, Reid AG, Vassiliou G, Hennig E, Franke C, Byrne J, Brizard A, Niederwieser D, Freeman-Edward J, Cuthbert G, Bown N, Clark RE, Nacheva EP, Green AR, Deininger MW (2003) Imatinib improves but may not fully reverse the poor prognosis of patients with CML with derivative chromosome 9 deletions. Blood 102:2205\u20132212","journal-title":"Blood"},{"key":"1002_CR12","unstructured":"ISCN (2009) An international system for human cytogenetic nomenclature. In: Shaffer LG, Tommerup N (eds) Karger"},{"key":"1002_CR13","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0165-4608(03)00204-8","volume":"147","author":"F Morel","year":"2003","unstructured":"Morel F, Herry A, Le Bris MJ, Morice P, Bouquard P, Abgrall JF, Berthou C, De Braekeleer M (2003) Contribution of fluorescence in situ hybridization analyses to the characterization of masked and complex Philadelphia chromosome translocation in chronic myelocytic leukemia. Cancer Genet Cytogenet 147:115\u2013120","journal-title":"Cancer Genet Cytogenet"},{"key":"1002_CR14","first-page":"35","volume":"85","author":"M Sessarego","year":"2000","unstructured":"Sessarego M, Fugazza G, Bruzzone R, Ballestrero A, Miglino M, Bacigalupo A (2000) Complex chromosome rearrangements may locate the bcr\/abl fusion gene sites other than 22q11. Haematologica 85:35\u201339","journal-title":"Haematologica"},{"key":"1002_CR15","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1182\/blood.V95.3.738.003k21_738_743","volume":"95","author":"PB Sinclair","year":"2000","unstructured":"Sinclair PB, Nacheva EP, Leversha M, Telford N, Chang J, Reid A, Bench A, Champion K, Huntly B, Green AR (2000) Large deletions at the t(9;22) breakpoint are common and may identify a poor-prognosis subgroup of patients with chronic myeloid leukemia. Blood 95:738\u2013743","journal-title":"Blood"},{"key":"1002_CR16","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.cancergencyto.2008.01.005","volume":"182","author":"V Soenen","year":"2008","unstructured":"Soenen V, Vigui\u00e9 F, La\u00ef JL, Andrieux J, Corm S, Roche-Lestienne C, Fi-LMC Group (2008) Mechanisms of genesis of variant translocation in chronic myeloid leukemia are not correlated with ABL or BCR deletion status or response to imatinib therapy. Cancer Genet Cytogenet 182:95\u2013102","journal-title":"Cancer Genet Cytogenet"},{"key":"1002_CR17","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0165-4608(02)00530-7","volume":"136","author":"CT Storlazzi","year":"2002","unstructured":"Storlazzi CT, Anelli L, Surace C, Lonoce A, Zagaria A, Nanni M, Curzi P, Rocchi M (2002) Molecular cytogenetic characterization of a complex rearrangement involving chromosomes 9 and 22 in a case of Ph negative chronic myeloid leukemia. Cancer Genet Cytogenet 136:141\u2013145","journal-title":"Cancer Genet Cytogenet"},{"key":"1002_CR18","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.cancergencyto.2005.11.008","volume":"166","author":"B Todori\u0107-Zivanovi\u0107","year":"2006","unstructured":"Todori\u0107-Zivanovi\u0107 B, Marisavljevi\u0107 D, Surace C, Cemeriki\u0107 V, Markovi\u0107 O, Krtolica K, Tatomirovi\u0107 Z, Cikota B, Magi\u0107 Z, Rocchi M (2006) A Philadelphia chronic myeloid leukemia with a complex BCR\/ABL rearrangement and a t(6;9)(p21;q34.1). Cancer Genet Cytogenet 166:180\u2013185","journal-title":"Cancer Genet Cytogenet"},{"key":"1002_CR19","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1038\/sj.leu.2401592","volume":"13","author":"JJ Dongen Van","year":"1999","unstructured":"Van Dongen JJ, Macintyre EA, Gabert JA et al (1999) Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukaemia for detection of minimal residual disease. Report of the BIOMOED-1 Concerted Action: investigation of minimal residual disease in acute leukaemia. Leukemia 13:1901\u20131928","journal-title":"Leukemia"},{"key":"1002_CR20","doi-asserted-by":"crossref","unstructured":"Wan TSK, Ma SK, Li CK, Chan LC (2004) Atypical in situ fluorescence in situ hybridisation pattern in chronic myeloid leukaemia due to cryptic insertion of BCR at 9q34. Leukemia 18:161\u2013162. author reply 162\u2013154","DOI":"10.1038\/sj.leu.2403197"},{"key":"1002_CR21","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.cancergencyto.2003.08.018","volume":"150","author":"A Zagaria","year":"2004","unstructured":"Zagaria A, Anelli L, Albano F, Storlazzi CT, Liso A, Roberti MG, Buquicchio C, Liso V, Rocchi M, Specchia G (2004) A fluorescence in situ hybridization study of complex t(9;22) in two chronic myelocytic leukemia cases with a masked Philadelphia chromosome. Cancer Genet Cytogenet 150:81\u201385","journal-title":"Cancer Genet Cytogenet"},{"key":"1002_CR22","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.cancergencyto.2006.01.011","volume":"167","author":"A Zagaria","year":"2006","unstructured":"Zagaria A, Anelli L, Albano F, Vicari L, Schiavone EM, Annunziata M, Pane F, Liso V, Rocchi M, Specchia G (2006) Molecular cytogenetic characterization of deletions on der(9) in chronic myelocytic leukemia. Cancer Genet Cytogenet 167:97\u2013102","journal-title":"Cancer Genet Cytogenet"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-011-1002-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-011-1002-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-011-1002-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,21]],"date-time":"2020-06-21T05:32:38Z","timestamp":1592717558000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-011-1002-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,8]]},"references-count":22,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["1002"],"URL":"https:\/\/doi.org\/10.1007\/s00432-011-1002-4","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,8]]}}}